Synergistic Arrythmia Origin Detection Systems

The present inventive concept integrates novel technologies, such as AI, IoT, blockchain, and graphene-based probes, with the original patent's cardiac invasive procedure to create a more powerful and accurate system for finding the origin of an arrythmia.

The original patent, 'Finding the origin of an arrythmia,' provides a method for analyzing results of a cardiac invasive procedure to locate the origin of a single-source arrythmia. However, this method has limitations in terms of accuracy, efficiency, and data security. The present inventive concept addresses these limitations by incorporating synergistic combinations of distinct technologies to enhance the accuracy and reliability of arrythmia origin detection.

The inventive concept encompasses a range of systems and methods that integrate the original patent's cardiac invasive procedure with advanced technologies. For instance, one embodiment utilizes an AI module to analyze LAT data and identify the arrythmia origin. Another embodiment incorporates IoT connectivity to transmit data to a cloud-based server for analysis. A blockchain-based data storage module can be used to ensure secure and tamper-proof data storage. Additionally, a novel, graphene-based probe can be employed to acquire LAT data with enhanced accuracy. These synergistic combinations enable the creation of a more powerful and accurate system for finding the origin of an arrythmia.

The inventive concept's novelty lies in the integration of distinct technologies, such as AI, IoT, blockchain, and graphene-based probes, with the original patent's cardiac invasive procedure. This synergistic combination provides a non-obvious solution to the limitations of the original patent, enhancing the accuracy and reliability of arrythmia origin detection.

Alternative embodiments of the inventive concept could include the use of virtual or augmented reality modules to create immersive representations of the heart chamber and arrythmia origin. Other variations could involve the integration of additional technologies, such as machine learning algorithms or novel materials, to further enhance the system's accuracy and efficiency.

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cardiac arrythmia diagnosis and treatment. The target market includes hospitals, clinics, and medical research institutions, as well as companies involved in the development of medical devices and technologies.